Training in Cardiovascular Research

心血管研究培训

基本信息

  • 批准号:
    9301343
  • 负责人:
  • 金额:
    $ 44.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-01 至 2020-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The T32-funded Cardiovascular Training Program at UT Southwestern has a long and illustrious history of fostering emergence of capable and productive investigators ideally positioned for independence and success. Indeed, our Program has an impressive track record, producing a large number of capable researchers who continue to have substantial impact. Over this period, our institution and the Division of Cardiology have evolved from a research emphasis heavily weighted towards basic science to one that now includes broad strength and representation in translational science, clinical trials, population-based research, and health services and outcomes research. The notification that our T32 competitive renewal did not meet criteria for refunding led us to critically examine all aspects of our program, to tear it down completely, and to rebuild it from scratch. Our new T32 application, while building on the strengths of our highly successful prior program, has been completely redesigned to address several important issues. Among the changes we have made include markedly reducing the number of trainees and restricting our program to postdoctoral fellows. The program is now evenly balanced between basic and clinical/translational research. The mentor pool has been modified substantially to include robust NIH-funded mentors in ancillary departments and to remove investigators who were not sufficiently productive or well funded. We have substantially enhanced our use of individualized development plans (IDPs). Our administrative structure has been redesigned to enhance oversight, to create a more unified institutional "home" for trainees, and to markedly strengthen bi-directional and ongoing evaluation of the trainees, mentors, and the training program. We have enhanced infrastructure support, including biostatistical support and assistance with IRB submissions. Also, multiple new initiatives have been implemented for female trainees. Our Cardiovascular Training Program is just that, a training program, and not a funding mechanism. Our primary objective is to develop the next generation of transformative cardiovascular investigators by recruiting highly talented and motivated individuals and preparing them for success in an increasingly competitive and resource-challenged environment. A secondary objective is to expand the cadre of women and minorities pursuing careers in cardiovascular research. Our faculty is diverse, spanning a spectrum of expertise from molecule to cell, organ system, organism, and population. Members of our faculty are distributed across the full spectrum of faculty rank, gender, and ethnic background. In summary, our Program is designed to foster the emergence of the next generation of investigators, teachers, and mentors at a time when the need for such has never been greater.
 描述(由适用提供):UT Southwestern的T32资助的心血管培训计划具有悠久而杰出的历史,可以促进有能力和产品调查人员的出现,理想地定位于独立性和成功。确实,我们的计划具有令人印象深刻的记录,产生了许多能够继续产生重大影响的能力的研究人员。在此期间,我们的机构和心脏病学分歧已经从大量加权基础科学的研究演变为现在,其中包括转化科学,临床试验,基于人群的研究以及卫生服务以及结果研究的广泛实力和代表性。我们的T32竞争性更新不符合退款标准的通知,使我们批判性地检查了 我们的程序将其完全拆除,并从头开始重建它。我们的新T32应用程序虽然基于我们非常成功的先前计划的优势,但已完全重新设计以解决几个重要问题。我们所做的更改包括明显减少了学员的数量并将我们的计划限制为博士后研究员。现在,该计划甚至在基本和临床/翻译研究之间达到平衡。精神库已经过大量修改,包括辅助部门的强大NIH资助的导师,并删除没有足够生产力或资金良好的调查人员。我们已经大大增强了对个性化开发计划(IDP)的使用。我们的行政结构已重新设计,以增强监督,为学员创建一个更统一的机构“家”,并明显加强对学员,导师和培训计划的双向和持续评估。我们增强了基础设施支持,包括生物统计学支持和IRB提交的援助。此外,为女学员实施了多项新计划。我们的心血管培训计划就是培训计划,而不是一种资金机制。我们的主要目标是通过招募有才华和成熟的个人,并为他们的成功做好准备,以在竞争激烈和资源挑战的环境中取得成功,从而开发下一代变革性的心血管调查员。次要目标是扩大从事心血管研究中从事职业的妇女和少数民族的干部。我们的教师是分歧,跨越了从分子到细胞,生物体,生物体和人群的一系列专业知识。我们教师的成员分布在各个教师等级,性别和种族背景中。总而言之,我们的计划旨在促进下一代调查人员,教师和导师的出现,而这一需要从未如此大。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSEPH A HILL其他文献

JOSEPH A HILL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSEPH A HILL', 18)}}的其他基金

Role of cGAS-STING in Afterload-Induced Cardiac Remodeling
cGAS-STING 在后负荷诱导的心脏重塑中的作用
  • 批准号:
    10625953
  • 财政年份:
    2023
  • 资助金额:
    $ 44.12万
  • 项目类别:
Cardiomyocyte bromodomain protein 4 (BRD4) in physiology and disease
心肌细胞溴结构域蛋白 4 (BRD4) 在生理学和疾病中的作用
  • 批准号:
    10471883
  • 财政年份:
    2020
  • 资助金额:
    $ 44.12万
  • 项目类别:
Cardiomyocyte bromodomain protein 4 (BRD4) in physiology and disease
心肌细胞溴结构域蛋白 4 (BRD4) 在生理学和疾病中的作用
  • 批准号:
    10681357
  • 财政年份:
    2020
  • 资助金额:
    $ 44.12万
  • 项目类别:
Cardiomyocyte bromodomain protein 4 (BRD4) in physiology and disease
心肌细胞溴结构域蛋白 4 (BRD4) 在生理学和疾病中的作用
  • 批准号:
    10241315
  • 财政年份:
    2020
  • 资助金额:
    $ 44.12万
  • 项目类别:
Training in Cardiovascular Research
心血管研究培训
  • 批准号:
    10454096
  • 财政年份:
    2015
  • 资助金额:
    $ 44.12万
  • 项目类别:
Training in Cardiovascular Research
心血管研究培训
  • 批准号:
    10663074
  • 财政年份:
    2015
  • 资助金额:
    $ 44.12万
  • 项目类别:
Training in Cardiovascular Research
心血管研究培训
  • 批准号:
    9033943
  • 财政年份:
    2015
  • 资助金额:
    $ 44.12万
  • 项目类别:
STIM1: Master Regulator of Calcium Homeostasis in Cardiomyocytes
STIM1:心肌细胞钙稳态的主调节器
  • 批准号:
    8605448
  • 财政年份:
    2013
  • 资助金额:
    $ 44.12万
  • 项目类别:
STIM1: Master Regulator of Calcium Homeostasis in Cardiomyocytes
STIM1:心肌细胞钙稳态的主调节器
  • 批准号:
    8722622
  • 财政年份:
    2013
  • 资助金额:
    $ 44.12万
  • 项目类别:
Foxo: Negative Regulator of Cardiac Hypertrophy
Foxo:心脏肥大的负调节因子
  • 批准号:
    7806527
  • 财政年份:
    2009
  • 资助金额:
    $ 44.12万
  • 项目类别:

相似国自然基金

CD40hiCD138hiPIR-Ahi巨噬细胞训练免疫的形成及其促进慢性排斥反应的机制研究
  • 批准号:
    82371794
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
面向底层视觉任务的通用自监督预训练基础模型研究
  • 批准号:
    62371164
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
认知原理启发的训练仿真系统战场空间表示方法研究
  • 批准号:
    62306329
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
支持深度伪造检测的精细化高效训练集生成方法研究
  • 批准号:
    62372423
  • 批准年份:
    2023
  • 资助金额:
    51 万元
  • 项目类别:
    面上项目
面向大规模图预训练模型的知识迁移关键问题研究
  • 批准号:
    62376129
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Bilirubin Catabolism induces Plasminogen-Activator Inhibitor 1 (PAI-1) worsening Metabolic Dysfunction
胆红素分解代谢诱导纤溶酶原激活剂抑制剂 1 (PAI-1) 恶化代谢功能障碍
  • 批准号:
    10750132
  • 财政年份:
    2024
  • 资助金额:
    $ 44.12万
  • 项目类别:
University of Louisville Biomedical Integrative Opportunity for Mentored Experience Development -PREP (UL-BIOMED-PREP)
路易斯维尔大学生物医学综合指导经验开发机会 -PREP (UL-BIOMED-PREP)
  • 批准号:
    10557638
  • 财政年份:
    2023
  • 资助金额:
    $ 44.12万
  • 项目类别:
Experiences of Discrimination, Dysbiosis, and Racial Disparities in Ovarian Cancer
卵巢癌中的歧视、生态失调和种族差异的经历
  • 批准号:
    10371537
  • 财政年份:
    2023
  • 资助金额:
    $ 44.12万
  • 项目类别:
The Role of Glycosyl Ceramides in Heart Failure and Recovery
糖基神经酰胺在心力衰竭和恢复中的作用
  • 批准号:
    10644874
  • 财政年份:
    2023
  • 资助金额:
    $ 44.12万
  • 项目类别:
Development and implementation of a digital sleep intervention for preschoolers in foster care
为寄养中的学龄前儿童开发和实施数字睡眠干预
  • 批准号:
    10724304
  • 财政年份:
    2023
  • 资助金额:
    $ 44.12万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了